ETFs Holding FCSC »    FCSC Historical Stock Prices »
FCSC News Video: Fri, Sep 25, 2015, 1:33 PM — Friday Sector Laggards: Metals & Mining, Biotechnology Stocks

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Fibrocell Science is an autologous cell and gene therapy company focused on translating personalized biologics for diseases affecting the skin and connective tissue. Co.'s development programs consist of the following: FCX-007, which is a genetically-modified autologous fibroblast that encodes the gene for type VII collagen for localized treatment of recessive dystrophic epidermolysis bullosa; FCX-013, which is an autologous fibroblast genetically-modified using lentivirus and encoded for matrix metalloproteinase 1; and Gene Therapy Research Program, which is in the research phase and is focused on the treatment of arthritis and related conditions. Self directed investors in Fibrocell Science Inc will be interested in keeping up with all Fibrocell Science Inc news they can find, both FCSC news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on FCSC. At RediNews, we simplify this task by presenting both FCSC news releases originating from Fibrocell Science Inc itself, and FCSC news from a variety of media outlets. Visitors can browse this news online and through our FCSC RSS news feed.


FCSC News — Articles, Videos, & Press Releases

Small Business Optimism Hits 4-Month High in April: 5 Picks
Wednesday, May 15, 2019, 6:11 AM — Zacks
Agenus (AGEN) Q1 Earnings Beat Estimates, Revenues Miss
Friday, May 10, 2019, 12:54 PM — Zacks
Puma Biotech (PBYI) Q1 Earnings Top, Nerlynx Disappoints
Friday, May 10, 2019, 8:00 AM — Zacks
Amicus' (FOLD) Earnings & Revenues Miss Estimates in Q1
Thursday, May 9, 2019, 1:21 PM — Zacks
IVERIC bio's (ISEE) Q1 Loss Narrows, Gene Therapy in Focus
Thursday, May 9, 2019, 1:03 PM — Zacks
AMAG Q1 Loss Wider Than Expected, Revenues Lag Estimates
Thursday, May 9, 2019, 4:57 AM — Zacks
Mylan's (MYL) Q1 Earnings Beat Estimates, Revenues Miss
Tuesday, May 7, 2019, 11:51 AM — Zacks
Analysts Predict 11% Gains Ahead For The Holdings of VXF
Tuesday, April 23, 2019, 7:52 AM — ETF Channel
ProQR Initiates Dosing in Phase II/III Eye Disorder Study
Tuesday, April 16, 2019, 5:26 PM — Zacks
Fibrocell Out-licenses Skin Disease Gene Therapy, Stock Rises
Tuesday, April 16, 2019, 8:59 AM — Zacks
FCSC is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:


Whether you use an enterprise information portal to update a corporate relations page, or have a handmade website with investor content in it, chances are you have come across the term "RSS" — Really Simple Syndication. Web page finance website experts and novices alike are welcome to integrate any of the RediNews RSS feeds found on the stock market content pages within our website. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): . Our news would be ideal paired with free stock chart and investor content, querying for the same specific stock ticker symbol presented to the user. While experience with flash and cobranded content would be ideal for integrating our news in a cool and unique way such as within a stock market ticker or stock screener feature, our feeds can also be integrated as extra links to enhance your financial portal content with dynamic stock content that updates every time there is new news tagged with the stock, giving your visitors another reason to check back to your website in the future.

FCSC News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.